With the analysis among 64 patents, we discovered top 13 key players by total patent application. Celmatix, Inc., Metabolomic Diagnostics Ltd., Interleukin Genetics, Inc. are dominant in this area. They take 35.94% of the total patent filing.
New York, United States
Patent: 13
Massachusetts, United States
Patent: 4
New Jersey, United States
Patent: 2
Missouri, United States
Patent: 1
Kentucky, United States
Patent: 1
Guangdong Sheng, China
Patent: 1
No data, please try another search term
With the analysis among related 66 patents applied in the last 5 years. We discover 35 most active companies in this area. The fast-growing Nanjing Maternal and Child Health Hospital, Metabolomic Diagnostics Ltd., Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences take 21.21% of patent filing during this period.
undefined undefined
Patent: 6
undefined undefined
Patent: 3
Shandong Sheng, China
Patent: 3
Missouri, United States
Patent: 2
New Jersey, United States
Patent: 2
With the analysis among related 66 patents in last 5 years, we discover 29 new entrants. Nanjing Maternal and Child Health Hospital, Metabolomic Diagnostics Ltd., Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences are the most active new entrants in this area.
undefined undefined
Patent: 6
undefined undefined
Patent: 3
Shandong Sheng, China
Patent: 3
Missouri, United States
Patent: 2
New Jersey, United States
Patent: 2
Colorado, United States
Patent: 2
With the analysis among 75 patents, we discovered top 15 universities and scientific research institutions by total patent application. The Chinese University of Hong Kong, Centre Hospitalier Universitaire de Montpellier, Statens Serum Institute are dominant in this area. They take 34.67% of the total patent filing.
Hong Kong SAR, China
Patent: 9
Hovedstaden, Denmark
Patent: 4
New York, United States
Patent: 3
Shandong Sheng, China
Patent: 3
Missouri, United States
Patent: 2
Virginia, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
Colorado, United States
Patent: 2